Medically Reviewed by: Dr. Dipak Ladda, M.D.
Expertise: Consultant Pathologist
Last Updated: July 14, 2026
Medical Analysis
Understanding Liver Function Tests (LFTs): A Comprehensive Guide to Hepatic Health
Liver Function Tests (LFTs), often referred to as a “Liver Panel” or “Hepatic Function Panel,” are not a single diagnostic test but rather a comprehensive blood profile. These tests are essential for evaluating the health and functionality of the liver, providing physicians with critical data to diagnose and monitor various hepatic conditions [1].
The liver performs numerous vital biological functions that maintain systemic homeostasis. It metabolizes carbohydrates, proteins, and lipids, ensuring stable glucose levels and preventing conditions like fatty liver. Furthermore, the liver synthesizes essential substances such as albumin, clotting factors, and cholesterol, which are crucial for maintaining normal protein levels and blood coagulation (PT) [13]. It acts as the body’s primary detoxification center, processing drugs, ammonia, and alcohol to prevent the accumulation of toxins. Additionally, the liver stores energy in the form of glycogen, along with vitamins and iron, preventing nutrient deficiencies, and it excretes waste products like bilirubin and cholesterol through bile [11, 13].
It is important to note that the “reality” of LFTs is that they represent an indirect mix of various enzymes, proteins, and waste markers. These tests provide clues regarding the specific type of liver injury but do not capture every function the liver performs [1]. The Hepatocellular Panel specifically detects injury markers—enzymes released into the bloodstream when liver cells are damaged—evaluates biliary function, including bile flow and signs of cholestasis, and measures the liver’s synthetic capacity to produce essential proteins [1, 13].
Interpreting Liver Enzyme Markers and Clinical Significance
Physicians utilize specific markers within the liver panel to differentiate between types of liver injury. The following table summarizes the primary markers and their clinical significance:
| Category | Marker | Clinical Significance |
| Hepatocellular Injury | ALT | More liver-specific; elevated in direct cell damage (Hepatitis, NAFLD) [1, 7]. |
| Hepatocellular Injury | AST | Less liver-specific; also rises in muscle injury or MI [1, 13]. |
| Hepatocellular Injury | AST:ALT Ratio | Often > 2:1 in alcoholic liver disease [3, 8]. |
| Cholestasis | ALP | Rises with bile duct obstruction; requires GGT to confirm liver origin [2, 9]. |
| Cholestasis | GGT | Highly sensitive for biliary disease; confirms ALP source is hepatic [9, 13]. |
| Synthetic Function | Albumin | Reflects long-term (chronic) synthetic capacity [13]. |
| Synthetic Function | PT/INR | Reflects acute changes in protein production and clotting ability [13]. |
The De Ritis Ratio: Evaluating Etiology of Liver Abnormalities
The ratios between Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) are vital for physicians in assessing the underlying cause of liver enzyme abnormalities [3]. AST is primarily located in the mitochondria of liver cells, while ALT exists primarily in the cytoplasm.
Under normal physiological conditions, the SAST/SALT (De Ritis) ratio is less than 1, typically between 0.7 and 0.9 [3]. If the ALT/AST ratio is greater than 1, liver cell injury must be considered, and timely treatment should be planned [8].
In cases of infectious hepatitis, other inflammatory conditions affecting the liver, and cirrhosis, ALT levels are usually as high as or higher than AST, often resulting in an ALT/AST ratio greater than 1.5 [8, 13]. Conversely, an AST/ALT ratio higher than 2:1 is a common indicator of alcoholic liver disease [3, 8].
De Ritis Ratio in Various Organs
The distribution of these enzymes is not limited to the liver, which can lead to diagnostic confusion if clinical context is ignored [8].
| Organs | ALT-U/L | AST-U/L | De Ritis Ratio | Notes |
| Liver | 10-40 | 15-55 | ~0.6-0.8 | Normal liver enzymes [1, 13] |
| Kidney | 100-300 | 100-580 | >1.0 | High AST and ALT relative to liver [13] |
| Heart | 900-1100 | 1400-2400 | >1.0 | High enzyme levels; AST > ALT [13] |
| Muscle | 30-40 | 150-200 | >3.0 | Markedly raised AST from muscle [13] |
| Lung | 200-250 | 400-450 | >1.5 | Elevated AST & ALT [13] |
| Pancreas | 20-40 | 70-120 | >1.5 | AST higher than ALT [13] |
| Brain | 30-60 | 80-110 | >1.5 | AST > ALT [13] |
| RBCS | 20 | 110-130 | >5.0 | Elevated AST & ALT [13] |
Bilirubin Metabolism and Excretion
Bilirubin metabolism is a multi-step process beginning with the breakdown of senescent red blood cells, which releases heme [6]. This Unconjugated (Indirect) Bilirubin is water-insoluble and is transported to the liver bound to albumin. Within the liver, the process of conjugation occurs, involving the UGT enzyme, which converts bilirubin into a water-soluble form [6, 13]. Finally, the Conjugated Bilirubin is excreted into the bile, eventually being eliminated from the body via feces (as stercobilin) and urine (as urobilinogen) [6].
Clinical Indications and Practical Considerations for LFTs
Liver Function Tests are indicated for several clinical scenarios, including:
Screening for potential liver infections [14].
Monitoring side effects of potentially toxic medications [7].
Evaluating clinical symptoms such as jaundice or abdominal pain [4].
Assessing the progression of known chronic liver diseases [2].
Checking the severity of hepatic scarring (cirrhosis) [10].
Investigating signs of heavy or chronic alcohol consumption [8].
Diagnosing suspected gallstones or biliary blockage [2, 4].
Measuring the liver’s protein production capacity [13].
Proper sample management is critical for accurate results. Serum or plasma samples (2.0 ml for blood, 1.8 ml for citrated plasma) should be stored at 2-8°C and transported using ice packs to maintain integrity [13].
For Non-Medicos: Understanding Liver Health Simply
The liver is the body’s main processing plant, responsible for energy storage, toxin removal, and making essential proteins. When doctors order a “Liver Function Test” (LFT), they are essentially checking the health of this facility by looking for “leaked” signs of damage [1].
Common LFT Markers Simplified
ALT & AST: These are “leakage” enzymes. When liver cells are injured, they spill these enzymes into your blood. ALT is more specific to the liver, while AST can also rise if your muscles or heart are stressed [8, 13].
ALP & GGT: These act like gauges for your bile ducts. If they are high, it might mean your bile flow is blocked [2].
Albumin & PT/INR: These measure your liver’s “output.” A healthy liver makes proteins for blood clotting and body maintenance. Low levels suggest the liver isn’t working at full capacity [13].
Interpreting Ratios and Non-Hepatic Causes
Sometimes, the ratio between markers tells us more than the levels themselves. For example, an AST level significantly higher than ALT is a common sign associated with heavy alcohol use [3]. Importantly, many markers are found in other body parts. For example, high ALP can be caused by bone disease, and high bilirubin might just mean your red blood cells are breaking down faster than usual, not necessarily that the liver is damaged [4, 13].
Limitations: The “Normal” Trap
It is crucial to remember that results cannot be viewed in isolation. A person can have “normal” test results even with underlying chronic liver issues like cirrhosis [1, 7]. Doctors must always interpret these blood results alongside your physical exam and clinical history [7]. Other factors, such as heart failure, diabetes, or even extreme exercise (which affects muscle enzymes), can “mimic” liver disease in these tests [13]. Always discuss your specific results with your healthcare provider to understand what they mean for your health [7].
References:
Lala, V., & Goyal, A. (2026). Liver Function Tests. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK482489/ Cited by: 726
Newsome, P. N., Cramb, R., Davison, S. M., et al. (2017). Guidelines on the management of abnormal liver blood tests. Gut, 67(1), 6–19. https://doi.org/10.1136/gutjnl-2017-314924 Cited by: 734
Botros, M., & Sikaris, K. A. (2013). The De Ritis ratio: The test of time. Clinical Biochemistry Review, 34(3), 117–130. https://pmc.ncbi.nlm.nih.gov/articles/PMC3866949/ Cited by: 709
Fargo, M. V., Grogan, S. P., & Saguil, A. (2017). Evaluation of Jaundice in Adults. American Family Physician, 95(3), 164–168. https://www.aafp.org/afp/2017/0201/p164 Cited by: 214
Fancher, T. L., & Gopal, D. V. (2017). Interpreting liver function tests. Consultant360. https://cdn-uat.mdedge.com/files/s3fs-public/Document/September-2017/0605CP_MedPsych.pdf Cited by: 15
Skurup, A. (n.d.). Hyperbilirubinemia and requirements to the determination of the concentration of bilirubin. Acutecaretesting.org. Cited by: 3
Prati, D., Taioli, E., Zanella, A., et al. (2002). Updated definitions of healthy ranges for serum alanine aminotransferase levels. Annals of Internal Medicine, 137(1), 1–10.
Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017). ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. The American Journal of Gastroenterology, 112(1), 18–35. https://doi.org/10.1038/ajg.2016.517
Giannini, E. G., Testa, R., & Savarino, V. (2005). Liver enzyme alteration: A guide for clinicians. Canadian Medical Association Journal, 172(3), 367–379. https://doi.org/10.1503/cmaj.1041071
Limdi, J. K., & Hyde, G. M. (2003). Evaluation of abnormal liver function tests. Postgraduate Medical Journal, 79(932), 307–312. https://doi.org/10.1136/pmj.79.932.307
American Association for the Study of Liver Diseases (AASLD). (2018). Diagnosis and management of nonalcoholic fatty liver disease: Practice guidance. Hepatology, 67(1), 328–357. https://doi.org/10.1002/hep.29367
Sherlock, S., & Dooley, J. (2002). Diseases of the Liver and Biliary System. Wiley-Blackwell.
Friedman, L. S., Martin, P., & Munoz, S. J. (2003). Laboratory evaluation of the patient with liver disease. AASLD Practice Guidelines.
Dufour, D. R., Lott, J. A., Nolte, F. S., et al. (2000). Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clinical Chemistry, 46(12), 2027–2049.
World Health Organization (WHO). (2017). Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. WHO Press.
FAQ’s:
What is a liver panel?
It is a blood profile used to evaluate liver health and diagnose various hepatic conditions.Why test liver function?
Tests help monitor infections, medication side effects, jaundice, and chronic liver disease progression.What do ALT/AST indicate? These enzymes are markers that leak into the blood when liver cells are damaged.
What is the De Ritis ratio?
It is the AST/ALT ratio used by physicians to determine the cause of liver abnormalities.Does high AST mean liver-only?
No, AST also rises due to muscle injury, heart conditions, or other non-hepatic issues.Why monitor bilirubin levels?
Increased bilirubin levels can signal liver dysfunction, biliary blockage, or red blood cell breakdown.What does ALP indicate?
Elevated ALP levels suggest bile duct obstruction, biliary disease, or certain bone conditions.Can tests be normal?
Yes, “normal” results do not guarantee a perfectly healthy liver, as seen in compensated cirrhosis.What is synthetic capacity?
It measures the liver’s ability to produce essential proteins like albumin for body function.How are samples stored?
Samples must be stored at 2-8°C and transported with ice packs to maintain testing integrity.
